Could ALK-ABELLO A/S SHARES -B- DENMARK (OTCMKTS:AKBLF) Change Direction After More Shorts?

April 17, 2018 - By Kenneth Lin

ALK-Abelló A/S (OTCMKTS:AKBLF) Logo

The stock of ALK-ABELLO A/S SHARES -B- DENMARK (OTCMKTS:AKBLF) registered an increase of 4.72% in short interest. AKBLF’s total short interest was 173,200 shares in April as published by FINRA. Its up 4.72% from 165,400 shares, reported previously. With 100 shares average volume, it will take short sellers 1732 days to cover their AKBLF’s short positions.

It closed at $122.8032 lastly. It is down 0.00% since April 17, 2017 and is . It has underperformed by 11.55% the S&P500.

ALK-Abelló A/S, a pharmaceutical company, develops, makes, and sells a range of products for the diagnosis and treatment of respiratory diseases and allergic asthma worldwide. The company has market cap of $1.17 billion. The firm offers allergy immunotherapy products, such as subcutaneous injections, sublingual droplets, and sublingual tablets. It currently has negative earnings. The Company’s allergy immunotherapy products are used for treating various allergies, including grass, ragweed, house dust mite, tree, Japanese cedar, cat, dog, and venom.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: